首页> 外文期刊>General Physiology and Biophysics >The effect of long-term administered CRAC channels blocker on the functions of respiratory epithelium in guinea pig allergic asthma model
【24h】

The effect of long-term administered CRAC channels blocker on the functions of respiratory epithelium in guinea pig allergic asthma model

机译:长期施用CRAC通道阻滞剂对豚鼠过敏性哮喘模型中呼吸道上皮功能的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Previously, therapeutic potency of CRAC channels blocker was evidenced as a significant decrease in airway smooth muscle hyperreactivity, antitussive and anti-inflammatory effects. The major role of the respiratory epithelium in asthma pathogenesis was highlighted only recently and CRAC channels were proposed as the most significant route of Ca2+ entry into epithelial cells. The aim of the study was to analyse the impact of long-term administered CRAC channels blocker on airway epithelium, e.g. cytokine production and ciliary beat frequency (CBF) using an animal model of allergic asthma. Ovalbumin-induced allergic airway inflammation of guinea pigs was followed by long-term (14 days lasted) therapy by CRAC blocker (3-fluoropyridine-4-carboxylic acid, FPCA). The influence of long-term therapy on cytokines (IL-4, IL-5 and IL-13) in BALF and in plasma, immunohistochemical staining of pulmonary tissue (c-Fos positivity) and CBF in vitro were used for analysis. Decrease in cytokine levels and in c-Fos positivity confirmed an anti-inflammatory effect of long-term administered FPCA. Cytokine levels in BALF and distribution of c-Fos positivity suggested that FPCA was a more potent inhibitor of respiratory epithelium secretory functions than budesonide. FPCA and budesonide reduced CBF only insignificantly. All findings supported CRAC channels as promising target in the new strategy of antiasthmatic treatment.
机译:以前,CRAC通道阻滞剂的治疗功效被证明是气道平滑肌反应过度,镇咳和抗炎作用的显着降低。呼吸上皮在哮喘发病机制中的主要作用仅在最近才被强调,而CRAC通道被认为是Ca2 +进入上皮细胞的最重要途径。该研究的目的是分析长期施用的CRAC通道阻滞剂对气道上皮的影响,例如使用过敏性哮喘的动物模型产生细胞因子产生和纤毛搏动频率(CBF)。卵白蛋白诱导的豚鼠过敏性气道炎症,然后通过CRAC阻断剂(3-氟吡啶-4-羧酸,FPCA)进行长期(持续14天)治疗。长期治疗对BALF和血浆中细胞因子(IL-4,IL-5和IL-13)的影响,体外肺组织的免疫组织化学染色(c-Fos阳性)和CBF用于分析。细胞因子水平和c-Fos阳性率的降低证实了长期服用FPCA的抗炎作用。 BALF中的细胞因子水平和c-Fos阳性分布表明,FPCA是比布地奈德更有效的呼吸道上皮分泌功能抑制剂。 FPCA和布地奈德仅微不足道地降低了CBF。所有发现均支持CRAC渠道成为抗哮喘新策略中有希望的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号